Azenta (AZTA) Cash & Current Investments (2010 - 2026)
Azenta (AZTA) posted quarterly Cash & Current Investments of $236.4 million for Q1 2026, down 7.55% year-over-year from $255.7 million in Q1 2025, and down 30.26% quarter-over-quarter from $339.0 million in Q4 2025.
Azenta (AZTA) Cash & Current Investments (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Cash & Current Investments for 17 consecutive years, with $236.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 7.55% year-over-year to $236.4 million; the TTM figure through Mar 2026 stood at $236.4 million (down 7.55% YoY), while the FY2025 annual figure was $339.0 million, changed N/A from the prior year.
- Cash & Current Investments slipped to $236.4 million in Q1 2026 per AZTA's latest filing, from $339.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $2.8 billion in Q1 2022 and bottomed at $236.4 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $799.6 million across 5 years, with a median of $595.8 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Current Investments soared 759.7% — and 2024, when it slumped 69.81%.
- Azenta's Cash & Current Investments stood at $1.1 billion in 2022, then slumped by 37.44% to $707.7 million in 2023, then sank by 46.37% to $379.6 million in 2024, then declined by 10.68% to $339.0 million in 2025, then slumped by 30.26% to $236.4 million in 2026.
- Business Quant data shows AZTA's Cash & Current Investments at $236.4 million in Q1 2026, $339.0 million in Q4 2025, and $340.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 863.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.68 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | 325.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 325.80 Mn |
| Mar 31, 2026 | 236.44 Mn |
| Dec 31, 2025 | 339.02 Mn |
| Sep 30, 2025 | 340.92 Mn |
| Jun 30, 2025 | 272.35 Mn |
| Mar 31, 2025 | 255.74 Mn |
| Dec 31, 2024 | 379.57 Mn |
| Sep 30, 2024 | 431.19 Mn |
| Jun 30, 2024 | 595.84 Mn |
| Mar 31, 2024 | 356.58 Mn |
| Dec 31, 2023 | 707.72 Mn |
| Sep 30, 2023 | 654.13 Mn |
| Jun 30, 2023 | 734.35 Mn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 2.18 Bn |
| Mar 31, 2022 | 2.75 Bn |
| Dec 31, 2021 | 215.22 Mn |
| Sep 30, 2021 | 234.57 Mn |